Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:edoxaban
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
B01AF03
|
| gptkbp:contraindication |
severe renal impairment
active pathological bleeding |
| gptkbp:drugClass |
gptkb:anticoagulant
|
| https://www.w3.org/2000/01/rdf-schema#label |
Savaysa
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Daiichi_Sankyo
|
| gptkbp:mechanismOfAction |
factor Xa inhibitor
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
bleeding rash |
| gptkbp:usedFor |
prevention of stroke in atrial fibrillation
treatment of deep vein thrombosis treatment of pulmonary embolism |
| gptkbp:bfsParent |
gptkb:edoxaban
|
| gptkbp:bfsLayer |
6
|